A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients

Qiang Guo; Kai Li; Ni Jiang; Rui Zhou; Xin-Rui Rao; Chuang-Yan Wu

doi:doi:10.18632/aging.205040

← Back

Research Paper Volume 15, Issue 18 pp 9633—9660

A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients

Figure 13. Risk model related to the immune cell markers in LUAD. (A) CSF1R; (B) STAT5A; (C) STAT5B; (D) ITGAM; (E) BCL6; (F) CD274; (G) ITGAX; (H) CD8B; (I) HLA-DPB1; (J) CD8A; (K) TGFB1; (L) HLA-DPA1; (M) IL21; (N) HLA-DQB1; (O) S4A4A; (P) CCR7; (Q) CD1C; (R) STAT3; (S) NRP1; (T)GZMB. Abbreviation: LUAD: lung adenocarcinoma.